Page last updated: 2024-08-24

imiquimod and Dermatosclerosis

imiquimod has been researched along with Dermatosclerosis in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aranegui, B; Jiménez-Reyes, J1
Bielsa Marsol, I1
Haddad, E; Hatami, A; Marcoux, D; McCuaig, CC; Piram, M; Powell, J; Saint-Cyr, C1
Bianchi, L; Campione, E; Chimenti, S; Diluvio, L; Orlandi, A; Paternò, EJ1
Doria, AS; Laxer, RM; Mohanta, A; Pope, E; Theriault, M1
Dytoc, M; Fiorillo, L; Man, J; Sawyer, D; Ting, PT1

Reviews

2 review(s) available for imiquimod and Dermatosclerosis

ArticleYear
Morphea in Childhood: An Update.
    Actas dermo-sifiliograficas, 2018, Volume: 109, Issue:4

    Topics: Acute-Phase Proteins; Bosentan; Calcitriol; Child; Child, Preschool; Female; Humans; Imiquimod; Immunosuppressive Agents; Incidence; Male; Phototherapy; Prevalence; Prognosis; Quality of Life; Scleroderma, Localized; Vitamin D

2018
Update on the classification and treatment of localized scleroderma.
    Actas dermo-sifiliograficas, 2013, Volume: 104, Issue:8

    Topics: Algorithms; Aminoquinolines; Clinical Trials as Topic; Eosinophilia; Fasciitis; Glucocorticoids; Humans; Imiquimod; Immunosuppressive Agents; Methotrexate; Photochemotherapy; Physical Therapy Modalities; Recurrence; Scleroderma, Localized; Severity of Illness Index

2013

Trials

1 trial(s) available for imiquimod and Dermatosclerosis

ArticleYear
Topical imiquimod 5% cream for pediatric plaque morphea: a prospective, multiple-baseline, open-label pilot study.
    Dermatology (Basel, Switzerland), 2011, Volume: 223, Issue:4

    Topics: Adjuvants, Immunologic; Adolescent; Aminoquinolines; Child; Dermis; Female; Humans; Imiquimod; Male; Ointments; Pilot Projects; Prospective Studies; Scleroderma, Localized; Skin Ulcer; Treatment Outcome; Ultrasonography

2011

Other Studies

3 other study(ies) available for imiquimod and Dermatosclerosis

ArticleYear
Short- and long-term outcome of linear morphoea in children.
    The British journal of dermatology, 2013, Volume: 169, Issue:6

    Topics: Adolescent; Adrenal Cortex Hormones; Age of Onset; Aminoquinolines; Calcitriol; Child; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Imiquimod; Male; Methotrexate; Ointments; Phototherapy; Retrospective Studies; Scleroderma, Localized; Tacrolimus; Treatment Outcome; Vitamin A; Vitamin E

2013
Localized morphea treated with imiquimod 5% and dermoscopic assessment of effectiveness.
    The Journal of dermatological treatment, 2009, Volume: 20, Issue:1

    Topics: Adjuvants, Immunologic; Administration, Cutaneous; Adult; Aminoquinolines; Biopsy, Needle; Dermoscopy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Risk Assessment; Sampling Studies; Scleroderma, Localized; Severity of Illness Index; Treatment Outcome; Young Adult

2009
First case series on the use of imiquimod for morphoea.
    The British journal of dermatology, 2005, Volume: 153, Issue:4

    Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aminoquinolines; Child; Drug Evaluation; Female; Follow-Up Studies; Humans; Imiquimod; Interferon Inducers; Male; Middle Aged; Scleroderma, Localized; Severity of Illness Index; Treatment Outcome

2005